Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
7
×
boston blog main
clinical trials
life sciences
national blog main
boston top stories
fda
national top stories
new york blog main
san diego blog main
san francisco blog main
deals
dyne therapeutics
investing
ipo
myotonic dystrophy type 1
rare disease drugs
renaissance capital
san diego top stories
480 biomedical
akouos
ally bridge group
antibiotics
arsenal medical
arvinas
astellas pharma
astellas pharmaceuticals
astrazeneca
atlas venture
audentes therapeutics
avidity biosciences
big data analytics
biotech ipos
blackrock
bluebird bio
bob langer
boulder/denver
boulder/denver blog main
boulder/denver top stories
What
ipo
7
×
medicines
company
drug
million
therapeutics
developing
genetic
new
raised
biotech
biotechs
brings
diseases
dyne
ipos
muscle
raises
rare
tests
treat
way
affects
ago
americans
analysis
approved
based
begin
bio
biosciences
bio’s
bring
bubbles
cells
chose
class
clinical
close
codiak
Language
unset
Current search:
ipo
×
boston
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
5 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way